ALLERGIC CONJUNCTIVITIS
Clinical trials for ALLERGIC CONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC CONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC CONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drop could soothe itchy, red eyes from allergies
Symptom relief Recruiting nowThis study tests a new eye drop called TL-925 for people with seasonal allergic conjunctivitis, which causes itchy, red eyes during allergy season. About 60 adults will receive either the active drop or a placebo. The goal is to see if TL-925 safely reduces eye itching and rednes…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Telios Pharma, Inc. • Aim: Symptom relief
Last updated May 26, 2026 03:11 UTC
-
New antibody shots aim to stop itchy eyes from birch pollen
Symptom relief Recruiting nowThis study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting to m…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Tear secrets revealed: new study maps eye disease fingerprints
Knowledge-focused Recruiting nowThis study collects and analyzes tears from 300 people with healthy eyes or with conditions like dry eye, eye infections, allergic conjunctivitis, or mucous membrane pemphigoid. The goal is to create a unique protein and metabolite "fingerprint" for each disease to better underst…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC